Duo Fight For Fingolimod Share In Canada

Patent-Infringement Actions Were Discontinued

Teva and Pharmascience are going head-to-head in a battle to capture the market for generic Gilenya fingolimod capsules in Canada.

Bears
Teva and Pharmascience are battling for share in Canada's fingolimod market • Source: Shutterstock

More from Products

More from Generics Bulletin